ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
2,1,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
3,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
4,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
5,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
5,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
5,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
6,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
7,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
8,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
8,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
9,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
9,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,3,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
10,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
11,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
12,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
13,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
14,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
15,1,Headache,Headaches NEC,Headaches,Nerv,N
15,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
16,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
17,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
18,1,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
18,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
19,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
19,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
19,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
20,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
21,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
22,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
23,1,Headache,Headaches NEC,Headaches,Nerv,N
23,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
23,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
24,2,Congenital musculoskeletal disorder of skull,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
25,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
25,2,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
25,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
25,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
26,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
26,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
28,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
29,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
29,4,Neonatal respiratory failure,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
29,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
31,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
32,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
33,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
34,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
35,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
36,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
36,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
36,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
36,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
37,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
37,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
37,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
38,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
38,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
38,4,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
38,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
40,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
41,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
42,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
43,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
43,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
43,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
45,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
46,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
46,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
47,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
47,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
48,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
49,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
49,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
49,3,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
49,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
50,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
51,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
52,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
53,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
54,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
55,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
56,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
57,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
58,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
59,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
60,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
61,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
62,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
63,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
64,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
65,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
66,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
67,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
68,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
69,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
70,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
71,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
71,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
72,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
73,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
73,2,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
73,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
74,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
75,1,Lactation insufficiency,Lactation disorders,Breast disorders,Repro,N
76,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
77,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
78,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
79,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
80,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
80,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
81,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
82,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
83,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
84,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
85,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
86,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
87,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
88,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
89,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
91,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
91,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
92,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
93,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
93,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
94,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
94,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
94,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
94,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
95,1,Migraine,Migraine headaches,Headaches,Nerv,N
95,2,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
96,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
96,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
97,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
97,3,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
98,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
99,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
105,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
106,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
107,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
108,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
110,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,2,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
111,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
111,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
111,3,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
111,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
111,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
111,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
113,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
114,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
120,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
120,2,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
120,3,Neonatal respiratory distress,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
120,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
120,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
121,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
121,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,1,Uterine atony,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
123,1,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
123,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
124,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
124,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
124,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
124,4,Uterine contractions during pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
125,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,2,Evacuation of retained products of conception,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
125,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
126,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
126,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,Y
127,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
127,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,Y
128,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
128,2,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
128,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
128,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
128,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
128,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
128,7,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
128,8,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
129,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
130,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
131,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
131,2,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
132,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
132,2,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,3,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
132,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
132,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
132,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
133,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
133,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
133,3,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
133,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
134,1,Base excess,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
134,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
134,3,Hypotonia neonatal,Muscle tone abnormalities,Muscle disorders,Musc,N
134,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
134,5,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
134,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
134,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
134,8,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
135,1,Retained placenta or membranes,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
136,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
136,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
136,3,Muscle necrosis,Myopathies,Muscle disorders,Musc,N
136,4,Pyometra,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
136,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
136,6,Uterine inversion,High risk pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
137,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
138,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
138,2,Uterine atony,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
139,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
139,2,Palatal oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
140,1,Dextrocardia,Cardiac malpositions congenital,Cardiac and vascular disorders congenital,Cong,N
140,2,Foetal alcohol syndrome,Chemically-induced congenital syndromes,Congenital and hereditary disorders NEC,Cong,N
140,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
140,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
140,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
141,2,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
141,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
141,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
141,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
141,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
141,7,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
141,8,Postmature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
141,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
141,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
141,11,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
142,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
142,2,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
142,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
142,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
142,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,6,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
142,7,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
142,8,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
142,9,PCO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
142,10,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
142,11,Prolonged pregnancy,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
142,12,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
142,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
142,14,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,15,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
143,1,Astigmatism,Refractive and accommodative disorders,Vision disorders,Eye,N
143,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
143,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
143,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
143,5,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
143,6,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
143,7,Retinal migraine,Migraine headaches,Headaches,Nerv,N
143,8,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
143,9,Retinal pallor,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
143,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
143,11,Visual field defect,Visual field disorders,Vision disorders,Eye,N
143,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
144,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
145,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
145,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
145,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,1,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
146,2,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
147,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
148,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
149,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
150,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
150,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
150,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
151,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
151,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
152,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
152,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
153,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
153,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
154,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
154,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
155,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
155,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
156,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
156,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
157,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
157,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
157,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
158,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
158,3,Uterine atony,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
159,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
159,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
159,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
159,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
159,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
160,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
161,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
161,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
161,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
162,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
162,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
163,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
164,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
164,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
165,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
165,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
165,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
165,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
165,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
165,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
165,8,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
165,9,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
165,10,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
165,11,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
165,12,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
165,13,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
165,14,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
165,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
165,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
165,17,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
165,18,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
165,19,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
165,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Administration site wound,Administration site reactions NEC,Administration site reactions,Genrl,N
166,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
166,3,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
166,4,Wound necrosis,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
167,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
168,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
168,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
168,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
169,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
170,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
170,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
170,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
170,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
171,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
171,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
172,1,Abnormal labour affecting foetus,Foetal conditions due to maternal conditions,Foetal complications,Preg,N
172,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
172,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
172,4,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
